Global Hepatitis B Therapeutics Market Value to Grow Slowly to $3.5 Billion by 2021, Finds New Report
The value of the global Hepatitis B Virus (HBV) therapeutics market will increase modestly over the next 6 years, from almost $3 billion in 2014 to $3.5 billion by 2021, representing a Compound Annual Growth Rate (CAGR) of 2.3%, according to new report.
View full press release